PMID: 7517185Jul 1, 1994Paper

Role of the lipopolysaccharide (LPS)-binding protein/CD14 pathway in LPS induction of tissue factor expression in monocytic cells

Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
S SteinemannN Mackman

Abstract

Endotoxic shock is associated with a coagulopathy, organ failure, and death. Tissue factor (TF) expression by monocytes exposed to bacterial endotoxin (lipopolysaccharide [LPS]) may mediate the coagulopathy and contribute to the high mortality of this disease. We examined the role of the LPS-binding protein (LBP)/CD14 receptor pathway in the LPS induction of TF expression in human monocytic THP-1 cells and peripheral blood monocytes. In THP-1 cells, the threshold concentration of LPS required to induce TF activity in serum-free medium was reduced 20-fold by purified LBP, which also enhanced TF mRNA synthesis. Similarly, monocytes cultured in the presence of serum were induced to express TF antigen at LPS concentrations 100 times lower than monocytes cultured in serum-free medium. An anti-LBP monoclonal antibody indicated that this effect was dependent on the presence of LBP in serum. LPS/LBP induction of TF activity and TF antigen expression in these monocytic cells were also inhibited by an anti-CD14 monoclonal antibody, indicating a requirement for the CD14 receptor. Thus, we suggest that low levels of LPS (5 to 100 pg/mL) present during sepsis induce TF expression in monocytes via the LBP/CD14-dependent pathway.

References

Jul 1, 1975·British Journal of Haematology·R P RiversW L Weston
Oct 1, 1991·Pigment Cell Research·P B NanningaW Westerhof
Apr 1, 1991·American Journal of Hematology·K OkajimaK Takatsuki
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S L WeinsteinA L DeFranco
Sep 21, 1990·Science·R R SchumannR J Ulevitch
Sep 1, 1986·The Journal of Experimental Medicine·P S TobiasR J Ulevitch
Jun 1, 1989·Molecular and Cellular Biology·S A GregoryT S Edgington
Nov 1, 1988·Thrombosis Research·J H MorrisseyT S Edgington
Feb 1, 1972·The Journal of Clinical Investigation·J Niemetz
Jun 1, 1983·The Journal of Clinical Investigation·M ColucciN Semeraro
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J PuginP S Tobias
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M A ReadJ Hawiger
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·P GallayM P Glauser
Apr 1, 1993·Immunobiology·J M MüllerP A Baeuerle
Jul 9, 1964·The New England Journal of Medicine·S I RAPAPORTP F HJORT

❮ Previous
Next ❯

Citations

Jan 1, 1996·Thrombosis Research·E CamererH Prydz
Jun 1, 1996·Veterinary Immunology and Immunopathology·P N BochslerR C Carroll
Nov 15, 1997·Thrombosis Research·T TennoA Siegbahn
Jul 25, 1998·Thrombosis Research·D M MartinH Prydz
Jul 15, 2003·Clinical Microbiology Reviews·Edwin S Van AmersfoortJohan Kuiper
Mar 3, 2010·American Journal of Respiratory and Critical Care Medicine·Sreerama ShettyRashmi S Shetty
Aug 8, 2015·American Journal of Respiratory and Critical Care Medicine·Keith R WalleyJohn H Boyd
Jun 10, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Katherine L LeicesterBruce R Bacon
Jul 28, 2009·Journal of Thrombosis and Haemostasis : JTH·F J Castellino, V A Ploplis
Oct 24, 2002·Critical Care Medicine·Nazima PathanMichael Levin
May 17, 2017·Journal of Thrombosis and Haemostasis : JTH·J B Kral-PointnerG Schabbauer
Feb 20, 2007·Veterinary Immunology and Immunopathology·Jin XuBenjamin J Darien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.